Blinatumomab 35mcg Injection — First-in-Class BiTE Antibody for Philadelphia Chromosome-Negative and Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukaemia
Trastuzumab Deruxtecan 100mg Injection — HER2-Targeted Antibody-Drug Conjugate for HER2-Positive and HER2-Low Breast Cancer, Gastric Cancer and HER2-Mutant NSCLC